VX1 vs Impala

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VX1
by Volta Medical
VS
Impala
by AliveCor

AI Verdict

These tools are adjacent rather than direct competitors, serving different phases of cardiac care. VX1 is designed to assist cardiac electrophysiologists in real-time during complex atrial fibrillation and tachycardia ablation procedures. In contrast, Impala is a portable, AI-powered 12-Lead ECG device focused on rapid diagnostic acquisition and detection of cardiac conditions for a broader range of healthcare professionals.

Choose VX1 if…

Choose VX1 if your electrophysiology lab requires real-time, AI-guided assistance during atrial fibrillation and atrial tachycardia ablation procedures. This tool is ideal for standardizing outcomes and reducing inter-operator variability by precisely identifying dispersed electrograms within existing EP mapping and recording systems.

View VX1 →

Choose Impala if…

Choose Impala if you are a healthcare professional needing a portable, AI-powered 12-Lead ECG device for rapid cardiac assessment in diverse clinical settings. This device is best suited for quickly acquiring diagnostic-quality ECGs with a reduced leadset to detect life-threatening cardiac conditions, including heart attacks.

View Impala →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature VX1 Impala
Pricing Contact for pricing Contact for pricing
Deployment Software integrated with existing electrophysiology (EP) lab mapping and recording systems. Portable device, integrated with mobile applications/platforms.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Impala

Impala is designed for portability and features a reduced lead set for easier placement, enabling rapid cardiac assessment by a broader range of healthcare professionals in diverse settings. While VX1 integrates into existing complex EP lab workflows, its usability is specific to highly specialized interventional procedures.

Clinical Value

VX1

VX1 offers real-time AI guidance during complex atrial fibrillation and atrial tachycardia ablation procedures, aiming to reduce inter-operator variability and standardize outcomes, which directly impacts the efficacy of a high-stakes therapeutic intervention. Impala provides crucial diagnostic capabilities for acute conditions, but VX1's focus is on refining and improving the success of a specific treatment.

Pricing & Value

Tie

Both VX1 and Impala require direct contact for pricing information, making it impossible to compare their cost-effectiveness or value proposition based on the provided facts or publicly available information.

Enterprise Readiness

Impala

Impala explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical assurances for data security, privacy, and legal compliance in enterprise healthcare environments. While VX1 is FDA-cleared and integrates into hospital systems, these specific enterprise-level data governance details are not explicitly provided in its facts.

Innovation

VX1

VX1's innovation lies in applying real-time AI to guide complex, invasive electrophysiology ablation procedures, analyzing 3D anatomical and electrical maps to improve precision and reduce variability during an ongoing intervention. This represents a more profound integration of AI into advanced surgical workflows compared to Impala's innovation in portable ECG acquisition and AI interpretation.

Support & Docs

Impala

AliveCor, the company behind Impala, has a history of providing extensive support resources, including user manuals and FAQs, which are generally more accessible given its broader user base. While Volta Medical provides support for VX1, specific documentation and public resources are less explicitly detailed compared to AliveCor's offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature VX1 Impala
Product Name VX1 Impala
Company Volta Medical AliveCor
Primary Function FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. Portable, AI-powered 12-Lead ECG device for healthcare professionals.
Key AI Application AI-guided real-time identification of dispersed electrograms (EGMs) during ablation procedures. AI technology (KAIu2122 12L) for cardiac determinations and detecting life-threatening cardiac conditions.
Target Medical Procedure/Setting During AFib and atrial tachycardia ablation procedures in an EP lab. Rapid cardiac assessment, portable 12-Lead ECG acquisition for healthcare professionals.
Specific Output/Capability Identifies dispersed electrograms, provides cycle length estimation, booster mode for increased sensitivity. Acquires and derives 12-Lead ECGs with a reduced leadset (single cable with 5 electrodes for 8 diagnostic-quality leads).

Videos

Demos, reviews, and walkthroughs featuring VX1 and Impala.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

VX1 is an FDA-cleared AI software designed to assist cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. Impala is a portable, AI-powered 12-Lead ECG device for healthcare professionals, intended for rapid cardiac assessment and detection of life-threatening cardiac conditions, including heart attacks.
VX1 provides AI-guided real-time identification of dispersed electrograms and analyzes 3D anatomical and electrical maps of human atria, aiming to reduce inter-operator variability. Impala utilizes AI technology (KAIu2122 12L) for cardiac determinations, including detecting 35 cardiac conditions (14 arrhythmias and 21 morphologies), and generates a full 12-Lead recording from a reduced leadset.
Impala explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, adhering to HIPAA and HITECH regulations. For VX1, HIPAA compliance and the presence of a BAA are not explicitly stated in the provided information.
VX1 is primarily designed for Cardiology, specifically to assist cardiac electrophysiologists during ablation procedures. Impala is designed for Cardiology and Emergency Medicine, facilitating rapid cardiac assessment by healthcare professionals in various settings.
No, VX1 is an AI software that assists operators in real-time identification of dispersed electrograms during AFib and atrial tachycardia ablation procedures. Impala, on the other hand, is a portable 12-Lead ECG device specifically designed for acquiring, storing, and transferring diagnostic ECGs.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring VX1 or Impala

Backers

Who funded each tool's parent company.

Impala

AI Tool Finder
AI-powered search. Results may not be comprehensive.